Pharmafile Logo
Pharmafocus logo
Advanced Search

Featured Interview on Industrial Design of Auto Injectors

June 4, 2015
Sales and Marketing auto injectors, ondrugdelivery, shl group

The necessity for auto injector has been growing rapidly over the years, spurring a variety of innovative designs to meet …

Feature
Thought Leadership
Shire image

Shire earns EMA nod for constipation drug

June 3, 2015
Sales and Marketing EMA, Resolor, Shire, constipation

Shire has seen approval from the European Medicines Agency to extend the licence of its constipation drug Resolor for men …

News
Keytruda image

Merck tests new Keytruda combination

June 3, 2015
Research and Development, Sales and Marketing Merck, dynavax, keytruda

Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …

News
Perrigo image

Perrigo buys OTC products from GSK

June 3, 2015
Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells

In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …

News
sophie_dyer

Clark Health Communications hires three

June 3, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications

Clark Health Communications (CHC) has announced the hire of three new team members. The UK, London-based firm has recently welcomed …

Appointment
NICE image

NICE: people should be more involved in medical decisions

June 2, 2015
Sales and Marketing NHS, NICE, medicines, optimisation

Around 15 million people in England now have at least one long-term condition, but figures suggest that as many as …

News
Bayer image

Bayer and Gilead expand in manufacturing

June 2, 2015
Manufacturing and Production, Sales and Marketing Bayer, Gilead, brett wells, manufacturing

Both Bayer and Gilead are investing heavily into their manufacturing operations with expansion plans being laid down in Indonesia and …

News
Roche logo

NICE signs-off Roche’s Gazyvaro for leukaemia

June 2, 2015
Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia

NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …

News
Mylan image

Mylan tells Teva to ‘stop playing games’ and make firm bid

June 2, 2015
Manufacturing and Production, Sales and Marketing M&A, MA, Mylan, Teva, generics

Mylan has written another strongly-worded letter to Teva, this time accusing the Israeli firm of ‘playing games’ and violating US …

News
corinne_le_goff

Amgen hires head of Europe from Roche

June 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Corinne Le Goff, Roche

Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …

Appointment

NICE Lynparza rejection labelled ‘hard to understand’

June 2, 2015
Sales and Marketing AstraZeneca, NICE, lynparza, olaparib

AstraZeneca has appealed to the government to put ‘urgent transitional measures’ in place to make sure patients can access innovative …

News
AZ image

AstraZeneca lung drug shines on

June 1, 2015
Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar

AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …

News
yervoy image

BMS immunotherapy combination impresses at ASCO

June 1, 2015
Research and Development, Sales and Marketing ASCO, BMS, Yervoy, opdivo

Bristol-Myers Squibb has presented data showing that a combination of its immunotherapies Opdivo and Yervoy significantly increases survival in advanced …

News

Pfizer breast cancer drug delivers

June 1, 2015
Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells

A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …

News
paolo_paoletti

Former GSK Oncology president joins Kesios

June 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, kesios

The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …

Appointment
web23andme-emilydrabant

Searching for new biotech solutions

June 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Emily Drabant Conley, google

For pharma, the elevator pitch for 23andMe is an intriguing prospect. It has the largest genetic database in the world, …

Feature
Opdivo

BMS’ Opdivo improves lung cancer survival

May 29, 2015
Research and Development, Sales and Marketing ASCO, BMS, Bristol-Myers Squibb, NSCLC, lung cancer, nivolumab, non-small cell lung cancer, opdivo

A Phase III trial of Bristol-Myers Squibb’s immunotherapy Opdivo has found it increases overall survival in people with a common …

News
novartis_window

NICE green-light for Novartis skin drug

May 29, 2015
Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab

NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …

News
lilly_logo_building

Lilly and AstraZeneca collaborate on cancer trials

May 29, 2015
Research and Development AstraZeneca, Cancer, Eli Lilly, MedImmune, immuno-oncology, immunotherapy, lilly, oncology, phase I

AstraZeneca and Eli Lilly are teaming up to run a clinical trial of two of the companies’ anti-cancer drugs. The …

News
Pfizer image

Pfizer gets first approval for rare lung disease

May 29, 2015
Sales and Marketing FDA, Pfizer, Rapamune, lung disease

Pfizer’s Rapamune will become the first drug available to treat the very rare lung disease lymphangioleiomyomatosis (LAM) after receiving approval …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026